He and colleagues reported higher levels of cancer antigen 125 in cervico-vaginal secretions of women with endometrial cancer (n = 148) compared to controls (n = 77), a finding that aligns with the small pilot study by Calis et al. This evidence concerns the gene MUC16 and endometrial cancer.